Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Base de dados
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Biomaterials ; 311: 122680, 2024 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38959534

RESUMO

In the present study, we explored the development of a novel noninvasive liposomal drug delivery material for use in intranasal drug delivery applications in human diseases. We used drug entrapment into liposomal nanoparticle assembly to efficiently deliver the drugs to the nasal mucosa to be delivered to the brain. The naturally occurring flavonoid 7,8-dihydroxyflavone (7,8-DHF) has previously been shown to have beneficial effects in ameliorating Parkinson's disease (PD). We used both naturally occurring 7,8-DHF and the chemically modified form of DHF, the DHF-ME, to be used as a drug candidate for the treatment of PD and l-DOPA induced dyskinesia (LID), which is the debilitating side effect of l-DOPA therapy in PD. The ligand-protein interaction behavior for 7,8-DHF and 6,7-DHF-ME was found to be more effective with molecular docking and molecular stimulation studies of flavonoid compounds with TrkB receptor. Our study showed that 7,8-DHF delivered via intranasal route using a liposomal formulation ameliorated LID in hemiparkinsonian mice model when these mice were chronically administered with l-DOPA, which is the only current medication for relieving the clinical symptoms of PD. The present study also demonstrated that apart from reducing the LID, 7,8-DHF delivery directly to the brain via the intranasal route also corrected some long-term signaling adaptations involving ΔFosB and α Synuclein in the brain of dopamine (DA) depleted animals.


Assuntos
Administração Intranasal , Flavonoides , Levodopa , Lipossomos , Animais , Lipossomos/química , Levodopa/administração & dosagem , Flavonoides/administração & dosagem , Flavonoides/farmacologia , Camundongos , Masculino , Doença de Parkinson/tratamento farmacológico , Camundongos Endogâmicos C57BL , Discinesia Induzida por Medicamentos/tratamento farmacológico , Simulação de Acoplamento Molecular , Receptor trkB/metabolismo , Sistemas de Liberação de Medicamentos , Flavonas
2.
Biomaterials ; 281: 121339, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-35078042

RESUMO

Ex vivo programming of T cells can be efficacious but is complex and expensive; therefore, the development of methods to transfect T cells in situ is important. We developed and optimized anti-CD3-targeted lipid nanoparticles (aCD3-LNPs) to deliver tightly packed, reporter gene mRNA specifically to T cells. In vitro, targeted LNPs efficiently delivered mCherry mRNA to Jurkat T cells, and T-cell activation and depletion were associated with aCD3 antibody coating on the surface of LNPs. aCD3-LNPs, but not non-targeted LNPs, accumulated within the spleen following systemic injection, with mCherry and Fluc signals visible within 30 min after injection. At 24 h after aCD3-LNP injection, 2-4% of all splenic T cells and 2-7% of all circulating T cells expressed mCherry, and this was dependent on aCD3 coating density. Targeting and transfection were accompanied by systemic CD25+, OX40+, and CD69+ T-cell activation with temporary CD3e ligand loss and depletion of splenic and circulating subsets. Migration of splenic CD8a+ T cells from the white-pulp to red-pulp, and differentiation from naïve to memory and effector phenotypes, followed upon aCD3-LNP delivery. Additionally, aCD3-LNP injection stimulated the secretion of myeloid-derived chemokines and T-helper cytokines into plasma. Lastly, we administered aCD3-LNPs to tumor bearing mice and found that transfected T cells localized within tumors and tumor-draining lymph nodes following immunotherapy treatment. In summary, we show that CD3-targeted transfection is feasible, yet associated with complex immunological consequences that must be further studied for potential therapeutic applications.


Assuntos
Lipídeos , Nanopartículas , Animais , Lipossomos , Camundongos , Fenótipo , RNA Mensageiro/genética , Transfecção
3.
Sci Rep ; 8(1): 4286, 2018 03 09.
Artigo em Inglês | MEDLINE | ID: mdl-29523826

RESUMO

Despite preliminary confidence on biosafety of polymer coated iron oxide nanoparticles (SPIONs), toxicity concerns have hampered their clinical translation. SPIONs toxicity is known to be due to catalytic activity of their surface and release of toxic Fe ions originating from the core biodegradation, leading to the generation of reactive oxygen species (ROS). Here, we hypothesized that a double-layer polymeric corona comprising of dextran as an interior, and polyethylene glycol (PEG) as an exterior layer better shields the core SPIONs. We found that ROS generation was cell specific and depended on SPIONs concentration, although it was reduced by sufficient PEG immobilization or 100 µM deferoxamine. 24 h following injection, PEGylated samples showed reduction of biodistribution in liver, heterogenous biodistribution profile in spleen, and no influence on NPs blood retention. Sufficient surface masking or administration of deferoxamine could be beneficial strategies in designing and clinical translation of future biomedical SPIONs.


Assuntos
Dextranos/química , Ferro/farmacocinética , Nanopartículas Metálicas/química , Polietilenoglicóis/química , Animais , Células Cultivadas , Coloides/química , Desferroxamina/farmacologia , Liberação Controlada de Fármacos , Feminino , Compostos Férricos/química , Ferro/toxicidade , Quelantes de Ferro/farmacologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Nanopartículas Metálicas/efeitos adversos , Camundongos , Células RAW 264.7 , Espécies Reativas de Oxigênio/metabolismo , Baço/efeitos dos fármacos , Baço/metabolismo , Distribuição Tecidual
4.
J Invest Dermatol ; 138(11): 2452-2460, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-29775632

RESUMO

Formation of scars after wounding or trauma represents a significant health care burden costing the economy billions of dollars every year. Activation of focal adhesion kinase (FAK) has been shown to play a pivotal role in transducing mechanical signals to elicit fibrotic responses and scar formation during wound repair. We have previously shown that inhibition of FAK using local injections of a small molecule FAK inhibitor (FAKI) can attenuate scar development in a hypertrophic scar model. Clinical translation of FAKI therapy has been challenging, however, because of the lack of an effective drug delivery system for extensive burn injuries, blast injuries, and large excisional injuries. To address this issue, we have developed a pullulan collagen-based hydrogel to deliver FAKI to excisional and burn wounds in mice. Specifically, two distinct drug-laden hydrogels were developed for rapid or sustained release of FAKI for treatment of burn wounds and excisional wounds, respectively. Controlled delivery of FAKI via pullulan collagen hydrogels accelerated wound healing and reduced collagen deposition and activation of scar-forming myofibroblasts in both wound healing models. Our study highlights a biomaterial-based drug delivery approach for wound and scar management that has significant translational implications.


Assuntos
Queimaduras/tratamento farmacológico , Cicatriz/tratamento farmacológico , Hidrogel de Polietilenoglicol-Dimetacrilato/uso terapêutico , Indóis/uso terapêutico , Inibidores de Proteínas Quinases/uso terapêutico , Pele/efeitos dos fármacos , Sulfonamidas/uso terapêutico , Cicatrização/efeitos dos fármacos , Animais , Células Cultivadas , Colágeno/química , Modelos Animais de Doenças , Sistemas de Liberação de Medicamentos , Feminino , Proteína-Tirosina Quinases de Adesão Focal/antagonistas & inibidores , Glucanos/química , Humanos , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Indóis/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Inibidores de Proteínas Quinases/farmacologia , Pele/patologia , Sulfonamidas/farmacologia
5.
Ann Biomed Eng ; 43(12): 2978-90, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26066056

RESUMO

Collagen makes up a large proportion of the human body, particularly the skin. As the body ages, collagen content decreases, resulting in wrinkled skin and decreased wound healing capabilities. This paper presents a method of delivering type I collagen into porcine and human skin utilizing a polyvinylpyrrolidone microneedle delivery system. The microneedle patches were made with concentrations of 1, 2, 4, and 8% type I collagen (w/w). Microneedle structures and the distribution of collagen were characterized using scanning electron microscopy and confocal microscopy. Patches were then applied on the porcine and human skin, and their effectiveness was examined using fluorescence microscopy. The results illustrate that this microneedle delivery system is effective in delivering collagen I into the epidermis and dermis of porcine and human skin. Since the technique presented in this paper is quick, safe, effective and easy, it can be considered as a new collagen delivery method for cosmetic and therapeutic applications.


Assuntos
Colágeno Tipo I/administração & dosagem , Sistemas de Liberação de Medicamentos , Agulhas , Administração Cutânea , Animais , Humanos , Técnicas In Vitro , Masculino , Microinjeções , Povidona , Pele/metabolismo , Suínos
6.
Biomaterials ; 37: 289-98, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25443792

RESUMO

Nanoparticle-mediated sustained delivery of therapeutics is one of the highly effective and increasingly utilized applications of nanomedicine. Here, we report the development and application of a drug delivery system consisting of polyethylene glycol (PEG)-conjugated liposomal nanoparticles as an efficient in vivo delivery approach for [Pyr1]-apelin-13 polypeptide. Apelin is an adipokine that regulates a variety of biological functions including cardiac hypertrophy and hypertrophy-induced heart failure. The clinical use of apelin has been greatly impaired by its remarkably short half-life in circulation. Here, we investigate whether [Pyr1]-apelin-13 encapsulation in liposome nanocarriers, conjugated with PEG polymer on their surface, can prolong apelin stability in the blood stream and potentiate apelin beneficial effects in cardiac function. Atomic force microscopy and dynamic light scattering were used to assess the structure and size distribution of drug-laden nanoparticles. [Pyr1]-apelin-13 encapsulation in PEGylated liposomal nanocarriers resulted in sustained and extended drug release both in vitro and in vivo. Moreover, intraperitoneal injection of [Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrated a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction. We concluded that this engineered nanocarrier system can serve as a delivery platform for treating heart injuries through sustained bioavailability of cardioprotective therapeutics.


Assuntos
Sistemas de Liberação de Medicamentos , Coração/efeitos dos fármacos , Coração/fisiopatologia , Peptídeos e Proteínas de Sinalização Intercelular/farmacologia , Lipossomos/química , Nanopartículas/química , Pressão , Animais , Portadores de Fármacos/química , Eletrocardiografia , Luz , Lipossomos/ultraestrutura , Camundongos , Microscopia de Força Atômica , Nanopartículas/ultraestrutura , Tamanho da Partícula , Espalhamento de Radiação
7.
Acta Biomater ; 9(8): 7767-74, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23648574

RESUMO

We present a method of fabricating microneedles from polyvinylpyrrolidone (PVP) that enables delivery of intact proteins (or peptides) to the dermal layers of the skin. PVP is known to self-assemble into branched hollow fibers in aqueous and alcoholic solutions; we utilized this property to develop dissolvable patches of microneedles. Proteins were dissolved in concentrated PVP solution in both alcohol and water, poured into polydimethylsiloxane templates shaped as microneedles and, upon evaporation of solvent, formed into concentric, fibrous, layered structures. This approach of making PVP microneedles overcomes problems in dosage, uniform delivery and stability of protein formulation as compared to protein-coated metallic microneedles or photopolymerized PVP microneedles. Here we characterize the PVP microneedles and measure the delivery of proteins into skin. We show that our method of fabrication preserves the protein conformation. These microneedles can serve as a broadly useful platform for delivering protein antigens and therapeutic proteins to the skin, for example for allergen skin testing or immunotherapy.


Assuntos
Injeções Intradérmicas/instrumentação , Microinjeções/instrumentação , Agulhas , Povidona/química , Proteínas/administração & dosagem , Desenho de Equipamento , Análise de Falha de Equipamento , Miniaturização
8.
Biomaterials ; 32(20): 4647-58, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21477858

RESUMO

Polyethylenimine (PEI) based polymers are efficient agents for cell transfection. However, their use has been hampered due to high cell death associated with transfection thereby resulting in low efficiency of gene delivery within the cells. To circumvent the problem of cellular toxicity, metal binding peptides were linked to PEI. Eight peptide-PEI derivatives were synthesized to improve cell survival and transfection efficiency. TAT linked PEI was used as a control polymer. Peptides linked with PEI amines formed nanogels as shown by electron microscopy and atomic force microscopic measurements. Polymers were characterized by spectroscopic methods and their ability to form complexes with plasmids was tested using electrophoretic studies. These modifications improved polymer biocompatibility as well as cell survival markedly, when compared to PEI alone. A subset of the modified peptide-polymers also showed significantly higher transfection efficiency in primary human cells with respect to the widely used transfection agent, lipofectamine. Study of the underlying mechanism of the observed phenomena revealed lower levels of 'reactive oxygen species' (ROS) in the presence of the peptide-polymers when compared to PEI alone. This was further corroborated with global gene expression analysis which showed upregulation of multiple genes and pathways involved in regulating intracellular oxidative stress.


Assuntos
Técnicas de Transferência de Genes , Peptídeos/química , Peptídeos/metabolismo , Polietilenoimina , Polímeros , Sequência de Aminoácidos , Animais , Terapia Genética/métodos , Células HEK293 , Humanos , Teste de Materiais , Dados de Sequência Molecular , Estrutura Molecular , Estresse Oxidativo , Peptídeos/genética , Polietilenoimina/química , Polietilenoimina/metabolismo , Polímeros/química , Polímeros/metabolismo , Células Estromais/citologia , Células Estromais/fisiologia
9.
Macromol Biosci ; 11(11): 1458-66, 2011 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-21994074

RESUMO

Cell-based therapies for wound repair are limited by inefficient delivery systems that fail to protect cells from the acute inflammatory environment. Here, a biomimetic hydrogel system is described that is based on the polymer pullulan, a carbohydrate glucan known to exhibit potent antioxidant capabilities. It is shown that pullulan hydrogels are an effective cell delivery system and improve mesenchymal stem cell survival and engraftment in high-oxidative-stress environments. The results suggest that glucan hydrogel systems may prove beneficial for progenitor-cell-based approaches to skin regeneration.


Assuntos
Antioxidantes/metabolismo , Biomimética/métodos , Glucanos/metabolismo , Hidrogéis/metabolismo , Lesões dos Tecidos Moles , Cicatrização/fisiologia , Animais , Antioxidantes/síntese química , Antioxidantes/farmacologia , Materiais Biocompatíveis/síntese química , Materiais Biocompatíveis/metabolismo , Materiais Biocompatíveis/farmacologia , Feminino , Glucanos/síntese química , Glucanos/farmacologia , Hidrogéis/síntese química , Peróxido de Hidrogênio/efeitos adversos , Peróxido de Hidrogênio/farmacologia , Espectroscopia de Ressonância Magnética , Células-Tronco Mesenquimais , Camundongos , Camundongos Endogâmicos , Estresse Oxidativo/efeitos dos fármacos , Espécies Reativas de Oxigênio/antagonistas & inibidores , Espécies Reativas de Oxigênio/metabolismo , Regeneração/efeitos dos fármacos , Lesões dos Tecidos Moles/metabolismo , Lesões dos Tecidos Moles/terapia , Cicatrização/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA